AVITA Medical Inc. (RCEL) NASDAQ
$7.96 (0.24) (-2.93%)
Market Cap: $211.56M
As of 05/16/24 03:47 PM EDT. Market open.
AVITA Medical Inc. (RCEL)
NASDAQ
$7.96
(0.24) (-2.93%)
Market Cap: $211.56M
As of 05/16/24 03:47 PM EDT. Market open.
Add to Portfolio
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Michael Perry
Full Time Employees
154
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Michael Perry
Full Time Employees
154
Address
28159 Avenue Stanford Ste 220, California, Valencia, 91355-2203.
PRICE CHART FOR AVITA MEDICAL INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.19
Previous Close
$8.20
Days Range
$8.12 - $8.97
52 week range
$7.51 - $21.70
Volume
270,542
Avg. Volume (30 days)
272,097
Market Cap
$211.56M
Dividend Yield
-
P/E
(4.72)
Shares Outstanding
25,799,735
Open
$8.19
Previous Close
$8.20
Days Range
$8.12 - $8.97
52 week range
$7.51 - $21.70
Volume
270,542
Avg. Volume (30 days)
272,097
Market Cap
$211.56M
Dividend Yield
-
P/E
(4.72)
Shares Outstanding
25,799,735
FINANCIAL STATEMENTS FOR AVITA MEDICAL INC
LOADING...
INSIDER TRANSACTIONS FOR AVITA MEDICAL INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
O'Toole David D | CFO | Feb 28, 2024 | Buy | $17.39 | 1,250 | 21,737 | 18,734 | Feb 28, 2024, 04:04 PM |
Shiroma Donna | General Counsel | Nov 30, 2023 | Option Exercise | $9.06 | 1,469 | 13,309 | 43,726 | Jan 05, 2024, 05:51 PM |
CORBETT JAMES | CEO | Dec 26, 2023 | Sale | $13.29 | 1,445 | 19,204 | 11,580 | Dec 27, 2023, 05:02 PM |
COOK JEREMY CURNOCK | Director | Dec 21, 2023 | Sale | $12.49 | 2,500 | 31,225 | 20,614 | Dec 22, 2023, 05:01 PM |
COOK JEREMY CURNOCK | Director | Dec 13, 2023 | Sale | $12.27 | 2,518 | 30,896 | 20,596 | Dec 14, 2023, 05:01 PM |
O'Toole David D | CFO | Dec 12, 2023 | Buy | $12.45 | 950 | 11,827 | 17,484 | Dec 12, 2023, 04:37 PM |
O'Toole David D | CFO | Nov 30, 2023 | Option Exercise | $9.06 | 1,034 | 9,369 | 16,034 | Dec 04, 2023, 07:06 PM |
O'Toole David D | CFO | Dec 01, 2023 | Buy | $10.68 | 500 | 5,340 | 16,534 | Dec 04, 2023, 07:06 PM |
O'Toole David D | CFO | Nov 21, 2023 | Buy | $10.28 | 2,000 | 20,560 | 15,000 | Nov 21, 2023, 04:15 PM |
O'Toole David D | CFO | Nov 15, 2023 | Buy | $12.45 | 1,000 | 12,450 | 13,000 | Nov 16, 2023, 02:38 PM |
O'Toole David D | CFO | Nov 16, 2023 | Buy | $12.15 | 1,000 | 12,150 | 12,000 | Nov 16, 2023, 02:38 PM |
O'Toole David D | CFO | Nov 15, 2023 | Buy | $13.25 | 1,000 | 13,250 | 11,000 | Nov 15, 2023, 04:31 PM |
O'Toole David D | CFO | Nov 14, 2023 | Buy | $12.88 | 1,000 | 12,880 | 10,000 | Nov 15, 2023, 04:31 PM |
Shiroma Donna | General Counsel | Aug 21, 2023 | Sale | $15.84 | 4,193 | 66,417 | 42,257 | Sep 08, 2023, 05:36 PM |
O'Toole David D | CFO | Aug 16, 2023 | Buy | $17.05 | 2,000 | 34,110 | 9,000 | Aug 16, 2023, 05:57 PM |
O'Toole David D | CFO | Aug 15, 2023 | Buy | $17.93 | 5,000 | 89,640 | 7,000 | Aug 15, 2023, 04:43 PM |
O'Toole David D | CFO | Jun 20, 2023 | Buy | $16.15 | 1,000 | 16,150 | 2,000 | Jun 21, 2023, 06:50 PM |
PERRY MICHAEL S | Director | Nov 21, 2022 | Option Exercise | $5.99 | 150,000 | 898,500 | 379,543 | Nov 22, 2022, 04:46 PM |
PERRY MICHAEL S | Director | Nov 21, 2022 | Sale | $7.18 | 150,000 | 1,077,000 | 229,543 | Nov 22, 2022, 04:46 PM |
PERRY MICHAEL S | Chief Executive Officer | Feb 24, 2022 | Sale | $8.74 | 10,812 | 94,497 | 321,712 | Feb 25, 2022, 04:54 PM |
Crowe Suzanne | Director | Sep 20, 2021 | Buy | $17.08 | 1,066 | 18,207 | 4,112 | Sep 21, 2021, 04:30 PM |
PERRY MICHAEL S | Chief Executive Officer | Sep 01, 2021 | Sale | $20.68 | 11,220 | 232,030 | 237,638 | Sep 07, 2021, 04:05 PM |
PERRY MICHAEL S | Chief Executive Officer | Jun 02, 2021 | Sale | $17.33 | 23,000 | 398,590 | 225,104 | Jun 04, 2021, 04:06 PM |
PERRY MICHAEL S | Chief Executive Officer | Sep 16, 2020 | Sale | $27.41 | 9,000 | 246,690 | 425,087 | Sep 16, 2020, 07:15 PM |
PERRY MICHAEL S | Chief Executive Officer | Sep 15, 2020 | Sale | $27.23 | 23,769 | 647,230 | 434,087 | Sep 16, 2020, 07:15 PM |
PERRY MICHAEL S | Chief Executive Officer | Sep 14, 2020 | Sale | $26.99 | 15,092 | 407,333 | 457,856 | Sep 16, 2020, 07:15 PM |
PERRY MICHAEL S | Chief Executive Officer | Sep 10, 2020 | Sale | $26.26 | 7,128 | 187,181 | 424,444 | Sep 11, 2020, 07:59 PM |
PERRY MICHAEL S | Chief Executive Officer | Sep 11, 2020 | Sale | $26.02 | 20,000 | 520,400 | 404,444 | Sep 11, 2020, 07:59 PM |
McIntyre David | Chief Financial Officer | Jul 17, 2020 | Buy | $22.70 | 393 | 8,921 | 893 | Jul 21, 2020, 04:18 PM |
McIntyre David | Chief Financial Officer | Jul 16, 2020 | Buy | $23.85 | 300 | 7,155 | 500 | Jul 21, 2020, 04:18 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
O'Toole David D | CFO | 02/28/2024 | 21,737 |
Shiroma Donna | General Counsel | 11/30/2023 | 13,309 |
CORBETT JAMES | CEO | 12/26/2023 | 19,204 |
COOK JEREMY CURNOCK | Director | 12/21/2023 | 31,225 |
COOK JEREMY CURNOCK | Director | 12/13/2023 | 30,896 |
O'Toole David D | CFO | 12/12/2023 | 11,827 |
O'Toole David D | CFO | 11/30/2023 | 9,369 |
O'Toole David D | CFO | 12/01/2023 | 5,340 |
O'Toole David D | CFO | 11/21/2023 | 20,560 |
O'Toole David D | CFO | 11/15/2023 | 12,450 |
O'Toole David D | CFO | 11/16/2023 | 12,150 |
O'Toole David D | CFO | 11/15/2023 | 13,250 |
O'Toole David D | CFO | 11/14/2023 | 12,880 |
Shiroma Donna | General Counsel | 08/21/2023 | 66,417 |
O'Toole David D | CFO | 08/16/2023 | 34,110 |
O'Toole David D | CFO | 08/15/2023 | 89,640 |
O'Toole David D | CFO | 06/20/2023 | 16,150 |
PERRY MICHAEL S | Director | 11/21/2022 | 898,500 |
PERRY MICHAEL S | Director | 11/21/2022 | 1,077,000 |
PERRY MICHAEL S | Chief Executive Officer | 02/24/2022 | 94,497 |
Crowe Suzanne | Director | 09/20/2021 | 18,207 |
PERRY MICHAEL S | Chief Executive Officer | 09/01/2021 | 232,030 |
PERRY MICHAEL S | Chief Executive Officer | 06/02/2021 | 398,590 |
PERRY MICHAEL S | Chief Executive Officer | 09/16/2020 | 246,690 |
PERRY MICHAEL S | Chief Executive Officer | 09/15/2020 | 647,230 |
PERRY MICHAEL S | Chief Executive Officer | 09/14/2020 | 407,333 |
PERRY MICHAEL S | Chief Executive Officer | 09/10/2020 | 187,181 |
PERRY MICHAEL S | Chief Executive Officer | 09/11/2020 | 520,400 |
McIntyre David | Chief Financial Officer | 07/17/2020 | 8,921 |
McIntyre David | Chief Financial Officer | 07/16/2020 | 7,155 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AVITA MEDICAL INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 1,749,580 | 0.00065% | -3.13% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 543,016 | 0.00081% | 2.72% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 209,257 | 0.03% | Exited | Growth |
AQR CAPITAL MANAGEMENT LLC | 90,600 | 0.00247% | 45.64% | Other |
D. E. SHAW & CO., INC. | 48,129 | 0.00066% | -4.8% | Other |
RENAISSANCE TECHNOLOGIES LLC | 23,600 | 0.00059% | -35.87% | Other |
CHANGE IN SHARES OUTSTANDING FOR AVITA MEDICAL INC
STOCK BUYBACKS FOR AVITA MEDICAL INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.31%
1Q
06/30/2023
0.95%
2Q
03/31/2023
1.10%
3Q
12/31/2022
1.58%
4Q
09/30/2022
1.89%
5Q
06/30/2022
2.03%
6Q
03/31/2022
2.17%
7Q
06/30/2021
2.52%
10Q
03/31/2021
12.07%
11Q
12/31/2020
17.83%
12Q
09/30/2020
18.49%
13Q
06/30/2020
19.26%
14Q
03/31/2020
20.10%
15Q
12/31/2019
28.18%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVITA MEDICAL INC
LOADING...